A prospective study of postmenopausal estrogen therapy and coronary heart disease

N Engl J Med. 1985 Oct 24;313(17):1044-9. doi: 10.1056/NEJM198510243131703.


To clarify the possible role of postmenopausal estrogen use in coronary heart disease, we surveyed 121,964 female nurses, aged 30 to 55 years, with mailed questionnaires, beginning in 1976. Information on hormone use and other potential risk factors was updated and the incidence of coronary heart disease was ascertained through additional questionnaires in 1978 and 1980, with a 92.7 per cent follow-up. End points were documented by medical records. During 105,786 person-years of observation among 32,317 postmenopausal women who were initially free of coronary disease, 90 women had either nonfatal myocardial infarctions (65 cases) or fatal coronary heart disease (25 cases). As compared with the risk in women who had never used postmenopausal hormones, the age-adjusted relative risk of coronary disease in those who had ever used them was 0.5 (95 per cent confidence limits, 0.3 and 0.8; P = 0.007), and the risk in current users was 0.3 (95 per cent confidence limits, 0.2 and 0.6; P = 0.001). The relative risks were similar for fatal and nonfatal disease and were unaltered after adjustment for cigarette smoking, hypertension, diabetes, high cholesterol levels, a parental history of myocardial infarction, past use of oral contraceptives, and obesity. These data support the hypothesis that the postmenopausal use of estrogen reduces the risk of severe coronary heart disease.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age Factors
  • Cholesterol / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / etiology*
  • Diabetes Complications
  • Estrogens / adverse effects*
  • Female
  • Humans
  • Hypertension / complications
  • Menopause*
  • Middle Aged
  • Myocardial Infarction / etiology
  • Prospective Studies
  • Risk
  • Surveys and Questionnaires
  • United States


  • Estrogens
  • Cholesterol